Inventiva (IVA) and Hepalys Pharma, a company incorporated in Japan and founded by Catalys Pacific, announced the initiation of the clinical ...

Thetis Pharmaceuticals LLC (“Thetis”), a clinical-stage company developing TP-317, a first-in-class, small molecule drug ...

Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). During the second quarter of fiscal year 2025, Incannex ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Recently published study focused on the evaluation of a novel etomidate analogue, methoxyethyl etomidate hydrochloride (ET-26), in healthy volunteers to assess its safety, tolerability, ...

Adial Pharmaceuticals received a U.S. patent for genetic marker-based treatment methods and completed a pharmacokinetics ...

By Tarun Sai Lomte A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high ...

Professor Saoirse O’Sullivan, Vice President Translational Science at Artelo Biosciences, is scheduled to deliver a presentation entitled, “A Cannabidiol Cocrystal (ART12.11) Tablet Has Comparable ...

No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11, ...

The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.